EPA:ALGBE - Euronext Paris - Matif - FR0011052257 - Common Stock - Currency: EUR
EPA:ALGBE (6/18/2025, 7:00:00 PM)
0.0905
-0.02 (-18.47%)
The current stock price of ALGBE.PA is 0.0905 EUR. In the past month the price decreased by -91.09%. In the past year, price decreased by -94.46%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
1DOW.MI | DOW INC | 14.49 | 18.76B | ||
2OY.DE | DOW INC | 24.85 | 17.74B | ||
FPE3.DE | FUCHS SE-PREF | 25.17 | 6.10B | ||
FPE.DE | FUCHS SE | 18.81 | 4.56B | ||
BEWI.OL | BEWI AS | N/A | 4.00B | ||
SOLV.BR | SOLVAC SA-REG | 17.56 | 1.87B | ||
LEN.DE | LENZING AG | N/A | 876.67M | ||
EXPL.PA | EXPLOSIFS PROD. CHI | 17.48 | 436.18M | ||
HYDRA.AS | HYDRATEC INDUSTRIES NV | 11.55 | 210.60M | ||
ALCRB.PA | CARBIOS | N/A | 122.33M | ||
SERI.MI | SERI INDUSTRIAL SPA | N/A | 119.30M | ||
HOLCO.AS | HOLLAND COLOURS NV | 15.34 | 98.04M |
Global Bioenergies SA develops industrial processes to convert renewable sources into isobutene. The company is headquartered in Evry, Ile-De-France and currently employs 43 full-time employees. The company went IPO on 2011-06-09. Isobutene, a hydrocarbon, can be converted into fuels such as isooctane, as well as into various materials (synthetic rubber, organic glass, plastics). The process developed by Global Bioenergies SA is based on the design of an artificial metabolic pathway comprising several enzymes catalyzing reactions not observed in nature. Six patent applications have been filed by the Company. The first two applications covering the key steps of the bio-production of isobutene and other olefins have already been published. The company distributes butane and propane containing bio-isobutene, in a e partnership with Global Bioenergies. The company operates through Syngip.
GLOBAL BIOENERGIES SA
5, rue Henri Desbrueres
Evry ILE-DE-FRANCE FR
Employees: 43
Phone: 33164982050
The current stock price of ALGBE.PA is 0.0905 EUR. The price decreased by -18.47% in the last trading session.
The exchange symbol of GLOBAL BIOENERGIES SA is ALGBE and it is listed on the Euronext Paris - Matif exchange.
ALGBE.PA stock is listed on the Euronext Paris - Matif exchange.
9 analysts have analysed ALGBE.PA and the average price target is 3.37 EUR. This implies a price increase of 3619.34% is expected in the next year compared to the current price of 0.0905. Check the GLOBAL BIOENERGIES SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
GLOBAL BIOENERGIES SA (ALGBE.PA) has a market capitalization of 1.64M EUR. This makes ALGBE.PA a Nano Cap stock.
GLOBAL BIOENERGIES SA (ALGBE.PA) currently has 43 employees.
The Revenue of GLOBAL BIOENERGIES SA (ALGBE.PA) is expected to grow by 0.97% in the next year. Check the estimates tab for more information on the ALGBE.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ALGBE.PA does not pay a dividend.
GLOBAL BIOENERGIES SA (ALGBE.PA) will report earnings on 2025-09-08.
GLOBAL BIOENERGIES SA (ALGBE.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.32).
ChartMill assigns a fundamental rating of 2 / 10 to ALGBE.PA. Both the profitability and financial health of ALGBE.PA have multiple concerns.
Over the last trailing twelve months ALGBE.PA reported a non-GAAP Earnings per Share(EPS) of -0.32. The EPS increased by 33.31% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -60.73% | ||
ROE | -346.31% | ||
Debt/Equity | 2.78 |
ChartMill assigns a Buy % Consensus number of 84% to ALGBE.PA. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 22.81% and a revenue growth 0.97% for ALGBE.PA